Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors
Clinical trial NCT02608385 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02608385
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2022-04-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.